1. Introduction

Animal genome governance refers to the legal, ethical, scientific and institutional framework governing the collection, sequencing, modification, ownership, storage, commercialization and use of animals’ genetic information.

An animal genome contains the genetic instructions that influence an animal’s development, physical characteristics, disease susceptibility, reproduction and biological functions. Advances in genome sequencing, gene editing, cloning and synthetic biology have created significant opportunities in agriculture, veterinary medicine, biodiversity conservation and scientific research. At the same time, these technologies raise questions about animal welfare, environmental safety, intellectual property, genetic-resource ownership and accountability.

Animal genome governance is not a single, universally codified area of law. It draws upon several legal fields, including:

Animal welfare and cruelty prevention.

Biotechnology and genetic engineering regulation.

Environmental and biodiversity conservation.

Patent and intellectual property law.

Veterinary medicine and agricultural regulation.

Research ethics and biosafety.

International trade and transboundary movement of genetic resources.

In India, the relevant framework includes the Prevention of Cruelty to Animals Act, 1960, the Environment (Protection) Act, 1986, the Biological Diversity Act, 2002, as amended, applicable rules governing genetically engineered organisms, and judicial decisions concerning animal welfare and environmental protection.

The central principle is that scientific control over an animal’s genome does not eliminate legal responsibilities toward the animal, the environment or the public.

2. Meaning and scope of animal genome governance

Animal genome governance covers the entire lifecycle of genetic research and application.

Genetic data collection

Obtaining tissue, blood, reproductive material or DNA sequences, with appropriate authority, consent where applicable, and ethical safeguards.

Research and genome modification

Regulating gene editing, cloning, transgenic animals and experimental breeding, including risks of pain, developmental abnormalities and inherited effects.

Safety assessment and authorization

Assessing animal health, environmental effects, genetic stability, disease transmission and potential impacts on wild populations.

Commercialization and accountability

Determining patent rights, access to genetic resources, liability for harm, traceability, monitoring and remedies for affected parties.

3. Principal legal issues

A. Animal welfare and humane treatment

Genome research may involve embryo manipulation, surgical procedures, reproductive interventions, cloning and the production of animals with altered physical characteristics. These activities may cause suffering or compromise an animal’s ability to live normally.

Animal welfare law therefore asks whether a research or commercial purpose justifies the procedure and whether less harmful alternatives exist.

In India, the Prevention of Cruelty to Animals Act, 1960, is a foundational statute. Its application depends on the conduct involved, relevant statutory provisions and any applicable exemptions or specialized research rules. The Committee for Control and Supervision of Experiments on Animals (CCSEA), formerly CPCSEA, administers important safeguards for covered animal experimentation.

Relevant governance requirements include:

Ethical review before covered experiments.

Appropriate housing, veterinary supervision and pain management.

Use of scientifically justified sample sizes and humane endpoints.

Assessment of unintended effects caused by genetic modification.

Continued welfare monitoring after birth or release from an experimental setting.

A genetic modification intended to increase productivity, for example, may be legally and ethically problematic if it predictably causes chronic pain, impaired mobility or serious reproductive complications.

B. Genetic engineering and biosafety

Genetically modified animals may create risks that extend beyond the laboratory. Modified organisms might escape, interbreed with wild populations, transfer genetic traits through breeding or disrupt ecosystems.

In India, the Environment (Protection) Act, 1986, and the rules notified under it for hazardous microorganisms and genetically engineered organisms, commonly known as the 1989 Rules, form an important part of the biosafety framework. Their precise application depends on the organism, activity and relevant regulatory provisions.

Institutional and regulatory bodies may include:

Institutional Biosafety Committees (IBSCs).

Review Committee on Genetic Manipulation (RCGM).

Genetic Engineering Appraisal Committee (GEAC), where the activity falls within its jurisdiction.

Other competent authorities responsible for containment, environmental release, import or export.

A sound regulatory assessment should consider not merely whether the intended genetic change works, but also whether unintended mutations, ecological effects, animal suffering or long-term consequences are reasonably foreseeable.

C. Ownership of animal genetic resources

Animal genome governance raises a difficult question: who may control genetic information obtained from an animal?

Potentially relevant interests include the owner of a domesticated animal, a breeder, a research institution, a patent holder, a community maintaining a traditional breed, and the state or public institutions responsible for biodiversity conservation.

These interests are not identical. Ownership of a physical animal does not automatically settle every question concerning genetic samples, sequence data, inventions derived from the animal or access to biological resources.

In India, the Biological Diversity Act, 2002, as amended, may be relevant to access to biological resources and associated knowledge, subject to its definitions, exclusions and applicable rules. Its application to a particular genetic sequence or digital sequence information issue requires careful legal analysis; it should not be assumed that every genome sequence is automatically governed in the same way as a physical biological sample.

D. Patents and intellectual property

Patent law may protect certain qualifying biotechnology inventions, including some genetic engineering techniques or engineered biological products. However, patent eligibility depends on the applicable statute, the nature of the claimed invention, exclusions, novelty, inventive step and disclosure requirements.

In India, the Patents Act, 1970, is particularly important. Section 3(j) excludes plants and animals in whole or any part thereof, other than microorganisms, as well as essentially biological processes for production or propagation of plants and animals, from patentability under its terms.

This does not mean that every invention related to animal genetics is necessarily unpatentable. A technical process, tool or other qualifying invention must be assessed according to the actual claims and statutory exclusions.

Patent governance should also consider whether exclusive rights over a technology could restrict veterinary treatment, conservation breeding or access to useful genetic resources.

4. Important case laws on animal genome governance

There is no single leading Indian judgment that comprehensively establishes a doctrine specifically called “animal genome governance.” The following cases provide important legal principles by analogy or direct application to animal welfare, genetic engineering, biodiversity and biotechnology.

Case 1: Animal Welfare Board of India v. A. Nagaraja (2014)

Supreme Court of India · (2014) 7 SCC 547

Facts: The case concerned jallikattu and bullock-cart races, including whether the treatment of bulls in these activities violated the Prevention of Cruelty to Animals Act, 1960.

Legal issue: How should statutory animal-welfare duties be interpreted when human activities cause animals unnecessary pain and suffering?

Decision: The Supreme Court held that the practices before it violated the applicable animal-welfare requirements. The Court emphasized the statutory duties under Sections 3 and 11 of the Act and discussed constitutional values relating to compassion for living creatures and environmental protection.

Indian Kanoon

+1

Relevance to animal genome governance: Although the case did not concern gene editing, its reasoning is relevant when assessing genetic interventions that produce pain, impaired mobility, reproductive difficulties or other welfare harms.

For example, if a research institution genetically modifies cattle to increase muscle growth but the modification causes severe locomotor problems, the institution cannot treat commercial productivity as the only relevant consideration. The applicable welfare rules and statutory duties must also be examined.

Legal principle: Scientific or commercial utility does not, by itself, remove the obligation to prevent unnecessary animal suffering.

Case 2: Animal Welfare Board of India v. Union of India (2023)

Supreme Court of India · 2023 INSC 548

Facts: The Court considered challenges to legislative amendments in Tamil Nadu, Karnataka and Maharashtra that permitted specified traditional animal-sport activities subject to statutory regulation.

Legal issue: Whether the amendments were constitutionally valid in light of earlier animal-welfare jurisprudence.

Decision: The Supreme Court upheld the challenged amendments, considering their legislative framework, regulatory safeguards and constitutional validity. It distinguished the amended statutory arrangements from the legal position considered in A. Nagaraja.

Indian Kanoon

+1

Relevance to animal genome governance: This judgment demonstrates that animal-related regulation must be assessed through the actual statutory framework in force. A broad welfare principle cannot replace analysis of the relevant legislation, regulatory conditions and factual evidence.

Applied to genetically modified animals, the question is not simply whether genetic intervention is morally controversial. It is whether the particular activity complies with the governing statutes, authorization requirements and applicable safeguards.

Legal principle: Animal-related activities must be evaluated within the current legislative framework, while respecting applicable constitutional and welfare constraints.

Case 3: N. R. Nair v. Union of India (2001)

Supreme Court of India · 2001 (3) SCR 353

Facts: The case involved the Central Government’s power to prohibit the training and exhibition of specified animals under Section 22 of the Prevention of Cruelty to Animals Act, 1960.

Legal issue: Whether the government's regulatory power was unguided or arbitrary.

Decision: The Supreme Court held that the power was constrained by the Act’s purpose and required a reasoned basis for concluding that the relevant activity would cause unnecessary pain or suffering. Judicial review could examine whether the decision ignored relevant facts or considered irrelevant matters.

IndiaCode

+1

Relevance to animal genome governance: Biotechnology regulators should similarly base consequential decisions on relevant scientific evidence, statutory authority and rational evaluation of risks.

For example, an authority considering a genetically modified animal should identify the relevant welfare and biosafety risks rather than approving or rejecting the technology solely because it is novel.

Legal principle: Regulatory discretion must operate within statutory limits and be supported by relevant material.

Case 4: Gene Campaign v. Union of India (2024)

Supreme Court of India · 2024 INSC 545 · Decided 23 July 2024

Facts: The litigation concerned the regulation and environmental release of genetically modified mustard, including the adequacy of regulatory decision-making and biosafety safeguards.

Legal issue: How should courts review decisions involving genetically engineered organisms, environmental risk and scientific uncertainty?

Significance: The Supreme Court's judgment addressed the regulatory framework for genetically modified crops and the constitutional and environmental issues surrounding their approval. The litigation illustrates the importance of transparent, scientifically informed regulatory decisions and appropriate environmental safeguards.

Indian Kanoon

Relevance to animal genome governance: The case concerns plants rather than animals, so its holdings must not be represented as directly deciding animal genome modification. Nevertheless, its broader regulatory issues are relevant by analogy when considering genetically engineered animals, especially where their release or breeding could affect ecosystems.

An approval process for a genetically modified animal should consider the nature of the organism, possible ecological consequences, the adequacy of the scientific record and the applicable legal requirements.

Legal principle: Biotechnology regulation requires legally authorized, evidence-based decision-making that properly addresses environmental and biosafety concerns.

Case 5: Association for Molecular Pathology v. Myriad Genetics, Inc. (2013)

Supreme Court of the United States · 569 U.S. 576 (2013)

Facts: The dispute concerned patents claiming isolated human genes associated with breast and ovarian cancer, as well as complementary DNA (cDNA).

Legal issue: Whether naturally occurring DNA becomes patentable merely because it has been isolated from its natural environment.

Decision: The Court held that naturally occurring DNA does not become patent-eligible merely through isolation, while synthetically created cDNA may be eligible, subject to the applicable legal requirements. Association for Molecular Pathology v. Myriad Genetics, Inc. concerned human DNA, not animal genomes.

Relevance to animal genome governance: The judgment provides a useful comparative framework for distinguishing the discovery of naturally occurring genetic information from a genuinely engineered invention.

It does not establish a universal rule for animal genome patents. Patentability of an animal-related invention depends on the jurisdiction, statutory exclusions, and precise claims.

In India, this comparison must be considered alongside Section 3(j) of the Patents Act, 1970, which excludes animals in whole or in part, subject to the statutory wording and relevant interpretation.

Legal principle: Discovery of genetic material and creation of a qualifying technical invention are legally distinct questions.

5. Constitutional and statutory framework in India

Animal genome governance is shaped by several overlapping legal sources.

These provisions do not automatically apply to every animal-genetics project in the same way. The species involved, the nature of the research, the source of the genetic material and whether an organism will be released into the environment are all relevant.

6. International principles of animal genome governance

International instruments contribute to the regulation of animal genetic resources, biosafety and conservation.

Convention on Biological Diversity (CBD), 1992. The CBD promotes biodiversity conservation, sustainable use and, within its scope, fair and equitable benefit-sharing from genetic resources. Its application to particular genetic data and digital sequence information requires attention to the relevant decisions and implementing rules.

Cartagena Protocol on Biosafety, 2000. This protocol establishes an international framework for the safe handling, transport and use of living modified organisms resulting from modern biotechnology, particularly in the context of transboundary movement. Its applicability depends on the organism and activity concerned.

Welfare and research standards. International veterinary and scientific standards encourage responsible animal experimentation, humane treatment, appropriate containment and risk assessment. Their binding force varies according to the relevant treaty, domestic legislation and institutional rules.

Together, these frameworks illustrate that genome governance is not confined to laboratory safety. It also concerns conservation, international movement, commercial access and the protection of animals and ecosystems.

7. Emerging legal challenges

A. CRISPR gene editing and unintended mutations

CRISPR and related techniques can alter targeted genetic sequences, but unintended changes and unpredictable biological effects remain possible.

The law must distinguish between a technically successful genetic modification and a safe, lawful and ethically justified intervention. Relevant safeguards include genetic validation, health monitoring, appropriate ethical approval and compliance with applicable biosafety requirements.

B. Animal cloning and reproductive technologies

Cloning can raise issues concerning pregnancy complications, developmental abnormalities, neonatal mortality and animal welfare.

A responsible governance system should assess both the procedure and the resulting animals. Where offspring inherit a modification, oversight may need to continue beyond the initial experiment.

C. Genomic databases and privacy

Animal genomic information can reveal valuable information about pedigree, breed characteristics, disease susceptibility and commercially valuable traits.

Governance should address access controls, data security, contractual permissions, retention periods and permissible commercial use. Although animal genomic information is not automatically personal data, records linked to identifiable farmers, breeders or individuals may raise separate privacy and confidentiality issues.

D. Indigenous and community-held genetic resources

Traditional livestock breeds may represent generations of community knowledge and selective breeding. Commercial use of these resources can raise questions concerning access, recognition and benefit-sharing.

The relevant legal analysis should identify the source of the material, applicable biodiversity legislation, contractual arrangements, community rights and any international obligations. Neither ownership of a specimen nor possession of a genome sequence alone necessarily resolves all these questions.

E. Release of genetically modified animals

A genetically modified animal released into the environment could reproduce, interact with wild populations or transmit genetic traits through breeding.

Regulatory assessment should therefore address ecological consequences, reversibility, monitoring, containment and contingency plans. Depending on the activity, prior authorization may be essential.

8. Core principles for an effective governance system

An effective animal genome governance framework should incorporate the following principles:

Precaution: Investigate credible risks before allowing activities that could cause serious or irreversible harm.

Proportionality: Match regulatory controls to the scale, likelihood and severity of the risks.

Animal welfare: Assess pain, distress, disease, reproduction and quality of life.

Scientific transparency: Document the evidence, limitations and uncertainties supporting regulatory decisions.

Traceability: Maintain reliable records of genetic modifications, breeding, transfers and adverse outcomes.

Accountability: Establish clear responsibility for researchers, institutions, breeders, manufacturers and regulators.

Environmental protection: Evaluate possible effects on biodiversity and wild populations.

Fair access and benefit-sharing: Apply relevant legal requirements to the use of genetic resources and associated knowledge.

Independent review: Provide appropriate ethical scrutiny, regulatory oversight and avenues for legal challenge.

Post-approval monitoring: Reassess safety when new evidence emerges and intervene where the law permits or requires it.

9. Application: A hypothetical case

Suppose a biotechnology company genetically modifies goats to produce a valuable pharmaceutical protein in their milk.

Several separate legal questions arise:

Animal welfare: Does the modification cause illness, discomfort, impaired fertility or other adverse effects?

Research authorization: Were the relevant animal experiments reviewed and conducted under the applicable rules?

Biosafety: Does the activity require specific authorization or containment measures?

Environmental risk: Could the animals escape or reproduce outside the controlled facility?

Intellectual property: Are the claimed inventions patentable under the relevant statutory provisions?

Product regulation: Does the resulting pharmaceutical require separate quality, safety and marketing approvals?

Liability: Who is responsible if the animals suffer harm or the modified organism causes legally actionable damage?

These questions cannot be answered by one general approval. Each regulatory obligation must be assessed independently, and approval under one legal regime does not necessarily satisfy the requirements of another.

10. Conclusion

Animal genome governance is an interdisciplinary legal field concerned with the responsible use of genetic technologies while protecting animal welfare, biodiversity and legitimate human interests.

The Indian decisions in Animal Welfare Board of India v. A. Nagaraja (2014), Animal Welfare Board of India v. Union of India (2023), and Gene Campaign v. Union of India (2024) illustrate different aspects of the legal principles relevant to this subject. The first concerns animal welfare, the second the constitutional validity of particular animal-sport legislation, and the third genetically modified crops and biosafety regulation. None should be mischaracterized as a direct judicial ruling establishing a comprehensive animal-genome code.

The central legal objective is to ensure that genetic innovation is conducted within the limits of statutory authority, scientifically justified safeguards, humane treatment and environmental responsibility. As gene editing, cloning and genomic data systems advance, stronger coordination between animal-welfare authorities, biotechnology regulators, biodiversity institutions and intellectual-property law will become increasingly important.

Academic note: For litigation, publication or a formal legal opinion, the current statutory text, applicable rules, subsequent amendments and the complete judgments should be verified before relying on any particular proposition.